However, all the BRCA1/2-positive patients and the ones with pathogenic/likely pathogenic variants in the genes for which clinical guidelines are available (e.g., TP53, MSH2, MLH1) were referred to appropriate genetic counseling with the reconstruction of the family history of cancer and the extension of the genetic test to the consenting relatives. This evidence concerns the gene BRCA1 and cancer.